Evidence map›Paper›PMID 36757366›Full record

ArticleeLife2023

Fitness advantage of

Daniel Hoces, Giorgia Greter, Markus Arnoldini, Melanie L Stäubli, Claudia Moresi, Anna Sintsova, Sara Berent, Isabel Kolinko, Florence Bansept, Aurore Woller and 6 more

Full text read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Identification and characterization of the lipoproteinProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Identification and Characterization of the LipoproteinbioRxiv : the preprint server for biology · 2024
    Article
  11. Review
  12. Article
  13. From microbiome composition to functional engineering, one step at a time.Microbiology and molecular biology reviews : MMBR · 2023
    Review
  14. Innate immune responses yield tissue-specific bottlenecks that scale with pathogen dose.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daniel HocesInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.ORCID 0000-0002-1451-5166
Giorgia GreterInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.
Markus ArnoldiniInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.
Melanie L StäubliInstitute of Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland.
Claudia MoresiInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.
Anna SintsovaInstitute of Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland.
Sara BerentInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.
Isabel KolinkoInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.
Florence BanseptSorbonne Université, CNRS, Institut de Biologie Paris-Seine (IBPS), Laboratoire Jean Perrin (LJP), Paris, France.ORCID 0000-0003-0562-9222
Aurore WollerSorbonne Université, CNRS, Institut de Biologie Paris-Seine (IBPS), Laboratoire Jean Perrin (LJP), Paris, France.
Janine HäfligerInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.
Eric MartensDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, United States.
Wolf-Dietrich HardtInstitute of Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-9892-6420
Shinichi SunagawaInstitute of Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID 0000-0003-3065-0314
Claude LoverdoSorbonne Université, CNRS, Institut de Biologie Paris-Seine (IBPS), Laboratoire Jean Perrin (LJP), Paris, France.ORCID 0000-0002-0888-1717
Emma SlackInstitute of Food, Nutrition and Health, Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland.ORCID 0000-0002-2473-1145

Funding

Swiss National Science Foundation 310030_185128Swiss National Science Foundation 40B2-0_180953Swiss National Science Foundation NCCR Microbiome
6 · The paper itself

Abstract

Many microbiota-based therapeutics rely on our ability to introduce a microbe of choice into an already-colonized intestine. In this study, we used genetically barcoded

Indexed as

Bacteroides thetaiotaomicronMicrobiotaAnimalsMicePolysaccharidesPolysaccharidesBacteroides thetaiotaomicroncapsular polysaccharidescolonizationinfectious diseasemathematical modelsmicrobiologymicrobiotamouse

Identifiers

PMID36757366
PMCPMC10014078

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read105
table measurements read7
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.